 | Up a level |
Chammartin, Frédérique; Griessbach, Alexandra; Kusejko, Katharina; Audigé, Annette; Epp, Selina; Stoeckle, Marcel P; Eichenberger, Anna L; Amstutz, Alain; Schoenenberger, Christof M; Hasse, Barbara; Braun, Dominique L; Rauch, Andri; Trkola, Alexandra; Briel, Matthias; Bucher, Heiner C; Günthard, Huldrych F; Speich, Benjamin; Abela, Irene A (2024). Bridging the Gap: identifying factors impacting mRNA SARS-CoV-2 vaccine booster response in people living with HIV-1. AIDS, 38(2), pp. 217-222. Wolters Kluwer Health 10.1097/QAD.0000000000003751
Perrig, Lisa; Abela, Irene A; Banholzer, Nicolas; Audigé, Annette; Epp, Selina; Mugglin, Catrina; Zürcher, Kathrin; Egger, Matthias; Trkola, Alexandra; Fenner, Lukas (2023). Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022. Swiss medical weekly, 153(12), p. 3502. EMH Schweizerischer Ärzteverlag 10.57187/s.3502
Griessbach, Alexandra; Chammartin, Frédérique; Abela, Irene A; Amico, Patrizia; Stoeckle, Marcel P; Eichenberger, Anna L; Hasse, Barbara; Braun, Dominique L; Schuurmans, Macé M; Müller, Thomas F; Tamm, Michael; Audigé, Annette; Mueller, Nicolas J; Rauch, Andri; Günthard, Huldrych F; Koller, Michael T; Trkola, Alexandra; Epp, Selina; Amstutz, Alain; Schönenberger, Christof M; ... (2023). Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2). Open Forum Infectious Diseases, 10(11), ofad536. Oxford University Press 10.1093/ofid/ofad536
Griessbach, Alexandra; Chammartin, Frédérique; Abela, Irene A; Amico, Patrizia; Stoeckle, Marcel P; Eichenberger, Anna L; Hasse, Barbara; Braun, Dominique L; Schuurmans, Macé M; Müller, Thomas F; Tamm, Michael; Audigé, Annette; Mueller, Nicolas J; Rauch, Andri; Günthard, Huldrych F; Koller, Michael T; Trkola, Alexandra; Epp, Selina; Amstutz, Alain; Schönenberger, Christof M; ... (2023). Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2). Open Forum Infectious Diseases, 10(4), ofad150. Oxford University Press 10.1093/ofid/ofad150
Speich, Benjamin; Chammartin, Frédérique; Abela, Irene A; Amico, Patrizia; Stoeckle, Marcel P; Eichenberger, Anna L; Hasse, Barbara; Braun, Dominique L; Schuurmans, Macé M; Müller, Thomas F; Tamm, Michael; Audigé, Annette; Mueller, Nicolas J; Rauch, Andri; Günthard, Huldrych F; Koller, Michael T; Trkola, Alexandra; Briel, Matthias; Kusejko, Katharina and Bucher, Heiner C (2022). Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial. Clinical infectious diseases, 75(1), e585-e593. Oxford University Press 10.1093/cid/ciac169
Audigé, Annette; Urosevic, Mirjana; Schlaepfer, Erika; Walker, Russell; Powell, Doug; Hallenberger, Sabine; Joller, Helen; Simon, Hans-Uwe; Dummer, Reinhard; Speck, Roberto F (2006). Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells. Journal of immunology, 177(9), pp. 6227-37. Bethesda, Md.: American Association of Immunologists
